Europe Contraceptives Market

Europe Contraceptives Market Size (2024 to 2029)

The size of the European contraceptives market is predicted to be worth USD 9.27 billion by 2029 from USD 6.76 billion in 2024, growing at a CAGR of 6.50% during the forecast period.

The rising awareness among the European population of the benefits of contraceptive methods in preventing pregnancy is one of the key factors propelling the European contraceptives market. Rising literacy rates among women and men are primarily contributing to this trend and resulting in increased demand for contraceptive methods. Women's healthcare organizations play a vital role in promoting awareness of these methods among the female population. In addition, the growing number of initiatives by the governments of European countries to educate both rural and urban populations on contraceptive methods adds fuel to the growth rate of the European market.

The rising prevalence of unplanned pregnancy further boosts the growth rate of the European contraceptives market. Unintended pregnancies can result in severe health difficulties, especially among young people. People use contraceptives to prevent unplanned pregnancies in such situations. In addition, the growing R&D efforts by the market participants to develop new and improved contraceptive devices and drugs favor the European contraceptives market. The researchers and manufacturers of contraceptives have been increasingly investing in R&D to develop pills and devices that minimize pain and side effects, which is estimated to boost the growth rate of the European market during the forecast period. Furthermore, the growing number of investments by governmental and non-governmental organizations in favor of contraceptives, an increasing number of clinical trial centers, and the growing number of product approvals contribute to regional market growth.

In addition, the increasing demand for long-acting contraceptives, the rising prevalence of sexually transmitted diseases (STDs), and the growing need for family planning fuel the growth rate of the European market. Furthermore, the growing availability of over-the-counter (OTC) contraceptives, rising disposable income and growing demand for hormonal contraceptives boost the European contraceptives market.

On the other hand, the high costs associated with contraceptives and treatment procedures where contraceptives are being used are one of the key factors hampering the growth rate of the European market. In addition, side effects such as menstrual bleeding pattern, pain, headaches, increased body weight and mood swings with the usage of contraceptive methods are another notable roadblocks to the growth rate of the European market. Furthermore, lack of awareness about contraception and lack of availability of various types of contraceptive methods in rural regions hinder regional market growth.

This research report on the European Contraceptives Market has been segmented & sub-segmented into the following categories:

Europe Contraceptive Market - By Drug Type: 

• Contraceptive Pills
• Topical Contraceptives
• Contraceptive Injectable
• Others (Contraceptive Gels, Jellies, and Creams)

Europe Contraceptive Market - By Medical Devices: 

• Male Contraceptive Devices (Condoms)
• Female Contraceptive Devices
  • Female Condoms
  • Intrauterine Devices
    • Hormonal IUD’s
    • Copper IUD’s
• Contraceptive Sponges
• Contraceptive Diaphragms
• Subdermal Contraceptive Implants
• Contraceptive Patches
• Non-Surgical Permanent Contraceptive Devices

Europe Contraceptive Market - By End User: 

• Hospitals
• Home Care
• Clinics
• Ambulatory Surgical Centres

Europe Contraceptive Market - By Country: 

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe

Geographically, Europe accounted for a substantial share of the global market in 2023 and is anticipated to hold a decent occupancy of the worldwide market during the forecast period. Germany, France, and the United Kingdom accounted for the largest share of the European market in 2023 and the same pattern is anticipated to repeat during the forecast period.

The UK led the market in 2023 and is anticipated to register a healthy CAGR during the forecast period. The growing awareness among the UK population regarding the benefits of contraceptives and investments by key market participants majorly drives the European market growth.

The German contraceptives market is expected to grow at a promising CAGR during the forecast period. The growing number of manufacturing centers and government-led family planning initiatives by the German government contribute to the German market growth. Oral pills are the most preferred contraceptive method among women in Germany.

The France contraceptives market is expected to progress steadily during the forecast period owing to the growing awareness among the population of France, increasing investments by the market participants to develop novel devices and favorable government measures by the Italian government. The growing number of initiatives by the French government in favor of contraceptives boosts the France market growth. Under the schemes of the French government, free birth control pills are being given to women below 25 years of age, which is expected to benefit 3 million women in France by providing them with pills, contraceptive patches, and other devices.

The contraceptives market in Spain is predicted to showcase a notable CAGR during the forecast period.

The Italy contraceptives market is estimated to grow at a noteworthy CAGR during the forecast period owing to the rising awareness of sexually transmitted diseases (STDs) and the rising prevalence of unplanned pregnancies.

KEY MARKET PLAYERS:

Bayer HealthCare AG, Teva Pharmaceutical Industries Limited, Medisafe Distribution Inc, Pace Pharmaceuticals Inc., Medicines360, Church & Dwight, Co., Inc., Actavis, Inc., CooperSurgical, Inc., Merck & Co., Inc., Reckitt Benckiser plc, Mayer Laboratories, Inc., and Pfizer, Inc. are some of the key players in the European contraceptives market.